{"nct_id":"NCT02137889","title":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL Patients","status":"TERMINATED","status_verified_date":"2018-02","start_date":"2012-07","start_date_type":null,"primary_completion_date":"2012-11","primary_completion_date_type":"ACTUAL","completion_date":"2012-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}